@article{28019,
  keywords = {Parasitic Diseases, Drug repositioning, Clinical use},
  author = {Ferreira L and Andricopulo AD},
  title = {Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective.},
  abstract = {<p>Identifying new indications for clinically useful drugs is a worthwhile approach for neglected tropical diseases. The number of successful repurposing cases in the field is growing as not-for-profit organizations, in association with academia and pharmaceutical companies, enable screening campaigns for the identification of new repositioning candidates. Current programs have delivered encouraging results as the use of state-of-the-art technologies, such as genomic and structural biology tools, and high-throughput screening platforms have become increasingly common in infectious disease research. Drug repositioning has played a key part in improving the lives of those suffering from these conditions, as evidenced by successful precedents and recent studies on preeminent parasitic disorders.</p>
},
  year = {2016},
  journal = {Drug discovery today},
  volume = {21},
  issn = {1878-5832},
  doi = {10.1016/j.drudis.2016.06.021},
  language = {eng},
}